Vivex Biomedical

14 articles about Vivex Biomedical

• VIVEX Biologics, Inc. Launches New CYGNUS® Dual Amniotic Allograft

  6/16/2023

  VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced that the Centers for Medicare and Medicaid Services has assigned a Q-code for its CYGNUS® Dual amniotic allograft product.

• VIVEX Biologics Announces Presentation of Clinical Results of VIA Disc® During Webinar Series Hosted by The American Society of Pain & Neuroscience (ASPN)

  5/19/2020

  First large randomized controlled trial to demonstrate clinically significant and objective benefit from treating the disc, the most common source of back pain Presentation to be part of continuing medical education (CME) event ATLANTA and MIAMI, May 19, 2020 (GLOBE NEWSWIRE) -- VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, today announced that results from the company’s VAST study, a 12-month trial

• Initial clinical results on VIA Disc presented at the 47th annual ISSLS

  6/6/2019

  The procedure offers a novel approach to current options in the continuum of care for treating Chronic Lower Back Pain.

• Vivex Biomedical, Inc. announces Lisa Colleran as the new CEO of the company

  10/23/2018

  Vivex Biomedical, a leading Regenerative Medicine company, announced today that Lisa Colleran has been appointed the new CEO.

• Vivex Biomedical Receives Level II HCPCS Q-Code For Cygnus, A Human Amniotic Tissue Allograft

  12/20/2016

• Onkos Surgical Enters Into Partnership With Vivex Biomedical

  4/19/2016

• Vivex Biomedical And Arthrex Enter Into Long Term Agreement

  3/31/2016

• Vivex Biomedical Announces Key Hire And Promotion

  3/17/2016

• Vivex Biomedical Gets $6.6M for Next-Gen Implant Tech

  1/6/2016

• Vivex Biomedical Announces New Chief Operating Officer of Tissue Bank

  3/3/2015

• Vivex Biomedical Announces Definitive Agreement With The University of Miami Marietta, GA/Miami, FL

  11/18/2014

• Vivex Biomedical And Akron Biotech: Collaborative Venture In Regenerative Medicine

  8/7/2014

• Vivex Biomedical Successfully Completes $7.6 Million Round of Financing

  9/19/2013

• Vivex Biomedical Raises $7.4 Million

  9/18/2013